Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
26.2M
-
Shares change
-
-3.4M
-
Total reported value, excl. options
-
$114M
-
Value change
-
-$10.4M
-
Put/Call ratio
-
3.59
-
Number of buys
-
36
-
Number of sells
-
-33
-
Price
-
$4.35
Significant Holders of Protara Therapeutics, Inc. - Common Stock (TARA) as of Q3 2025
93 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock as of Q3 2025.
Protara Therapeutics, Inc. - Common Stock (TARA) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.2M shares
of 38.5M outstanding shares and own 68.13% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (4.23M shares), BlackRock, Inc. (2.23M shares), Velan Capital Investment Management LP (2.14M shares), Blackstone Inc. (1.91M shares), VANGUARD GROUP INC (1.9M shares), ACORN CAPITAL ADVISORS, LLC (1.75M shares), Catalio Capital Management, LP (1.5M shares), Integral Health Asset Management, LLC (1.4M shares), UBS Group AG (843K shares), and 5AM Venture Management, LLC (800K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.